Massachusetts Biotechnology Council CEO Issues Innovation Policy Update on Sept. 10, 2026
September 11, 2026
September 11, 2026
CAMBRIDGE, Massachusetts, Sept. 11 -- The Massachusetts Biotechnology Council issued the following statement on Sept. 10, 2026, by CEO Kendalle Burlin O'Connell:
* * *
CEO Innovation Policy Update 09.10.26
Congress is back next week and biotechnology competitiveness and biosecurity remain a priority. At the same time, several Administration nominations are being considered in the Senate next week while FDA continues efforts to stabilize leadership. Her . . .
* * *
CEO Innovation Policy Update 09.10.26
Congress is back next week and biotechnology competitiveness and biosecurity remain a priority. At the same time, several Administration nominations are being considered in the Senate next week while FDA continues efforts to stabilize leadership. Her . . .